SCHEMBL34095

SCHEMBL34095

C=C(C)C(=O)N[N+](C)(C)CCC

nearest known ligand 0.33

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
TGFBR1 P36897 1/20 0.33
ALDH1A1 P00352 2/20 0.32
KDM4E B2RXH2 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL7945238 0.98 TSHR (0.32) TGFBR1ALDH1A1KDM4E
SCHEMBL9188552 0.87 ALDH1A1 (0.31) TGFBR1ALDH1A1
SCHEMBL2773074 0.85 TSHR (0.41)
SCHEMBL6222153 0.85 TSHR (0.41)
Hydrochloric Acid SCHEMBL4102058 0.83 TSHR (0.43)
SCHEMBL3776845 0.83 TGFBR1 (0.35) TGFBR1ALDH1A1KDM4E
Hydrochloric Acid SCHEMBL3866989 0.81 TGFBR1 (0.34) TGFBR1ALDH1A1KDM4E
SCHEMBL7202524 0.81 TGFBR1 (0.34) TGFBR1ALDH1A1
Hydrochloric Acid SCHEMBL10534466 0.80
Hydrochloric Acid SCHEMBL6845645 0.79 TSHR (0.33) TGFBR1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1966 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1357884-B2 COMPOSITION FOR TREATING KERATINOUS MATERIALS COMPRISING A CATIONIC POLY(ALKYL) VINYLLACTAM POLYMER AND A CONDITIONING AGENT OREAL (FR) 2019-11-13 EP claimed
WO-2014044660-A1 COSMETIC ASSEMBLY AND COSMETIC COMPOSITION COMPRISING AN ANIONIC SURFACTANT, A SOLID FATTY ALCOHOL AND A CATIONIC POLYMER, COSMETIC TREATMENT PROCESS AND CONDITIONING DEVICE L'OREAL (FR) 2014-03-27 WO claimed
US-8361484-B2 Polymer systems for lung volume reduction therapy AERIS THERAPEUTICS, INC. (US) 2013-01-29 US claimed
EP-1357884-B1 COMPOSITION FOR TREATING KERATINOUS MATERIALS COMPRISING A CATIONIC POLY(ALKYL) VINYLLACTAM POLYMER AND A CONDITIONING AGENT OREAL (FR) 2010-04-28 EP claimed
US-20100040538-A1 Polymer Systems for Lung Volume Reduction Therapy CANADIAN IMPERIAL BANK OF COMMERCE (CA) 2010-02-18 US claimed
EP-1814511-B1 METHOD FOR THE PERMANENT SHAPING OF HAIR USING A CATIONIC CELLULOSE DERIVATIVE PROCTER & GAMBLE (US) 2009-12-23 EP claimed
EP-2059227-A2 POLYMER SYSTEMS FOR LUNG VOLUME REDUCTION THERAPY Aeris Therapeutics, Inc. (US) 2009-05-20 EP claimed
EP-2046932-A2 COMPOSITION FOR IMPROVING WETTABILITY OF SURFACES Ciba Holding Inc. (CH) 2009-04-15 EP claimed
WO-2008039827-A2 POLYMER SYSTEMS FOR LUNG VOLUME REDUCTION THERAPY AERIS THERAPEUTICS, INC. (US) 2008-04-03 WO claimed
WO-2008015138-A2 COMPOSITION FOR IMPROVING WETTABILITY OF SURFACES CIBA HOLDING INC. (CH) 2008-02-07 WO claimed
WO-2000056283-A1 INHIBITION OF MATRIX METALLOPROTEINASES WITH POLYMERS AND PHARMACEUTICAL APPLICATIONS THEREOF THE B.F.GOODRICH COMPANY (US) 2000-09-28 WO claimed
EP-0807151-B1 POLYMERIC EARTH SUPPORT FLUID COMPOSITIONS AND METHOD FOR THEIR USE KB TECHNOLOGIES LTD (US) 2000-08-16 EP claimed
EP-0997515-A1 Polymeric earth support fluid compositions and method for their use KB TECHNOLOGIES LTD. (US) 2000-05-03 EP claimed
WO-2000020527-A1 DRILLING FLUID ADDITIVE AND PROCESS THEREWITH PHILLIPS PETROLEUM COMPANY (US) 2000-04-13 WO claimed
WO-1998034994-A1 COMPOSITION AND METHOD FOR A DUAL-FUNCTION SOIL-GROUTING EXCAVATING OR BORING FLUID KB TECHNOLOGIES, LTD. (US) 1998-08-13 WO claimed
EP-0807151-A1 POLYMERIC EARTH SUPPORT FLUID COMPOSITIONS AND METHOD FOR THEIR USE KB TECHNOLOGIES LTD. (US) 1997-11-19 EP claimed
US-5663123-A POLYMERS FOR BORE HOLES TO STABILIZE EARTH IN DRILLING AND EXCAVATION KB TECHNOLOGIES LTD. (US) 1997-09-02 US claimed
WO-1996023849-A1 POLYMERIC EARTH SUPPORT FLUID COMPOSITIONS AND METHOD FOR THEIR USE KB TECHNOLOGIES LTD. (US) 1996-08-08 WO claimed
EP-0559851-B1 HAIR-SETTING AGENT AND A HAIR-PERMING METHOD USING THIS AGENT WELLA AG (DE) 1995-08-23 EP claimed
US-5349023-A Vinyl alcohol copolymer having terminal amino group KURARAY CO., LTD. (JP) 1994-09-20 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100040538-A1 Polymer Systems for Lung Volume Reduction Therapy GFER, MUC1, CTH TGFBR1 700/4885ALDH1A1 1749/4885KDM4E 1589/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.